Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emperion is a national URAC-accredited provider that supplies Independent Medical Examinations (IME), Peer Reviews (PR), Functional Capacity Exams (FCE), and Independent Review Organization (IRO) services. The company serves workers' compensation, automobile, disability, and health sectors through a national provider network of approximately 25,000 medical specialists across 8 regional service centers and 35+ clinics. In 2025, Emperion agreed to acquire PeerLink, expanding its clinical review service capabilities. The business spun out of Enlyte/Genex IME in 2024 and is led by experienced management from those entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emperion.